{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:03:07Z","timestamp":1769115787744,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["19J11266"],"award-info":[{"award-number":["19J11266"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["JP17H04758"],"award-info":[{"award-number":["JP17H04758"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["18H03187"],"award-info":[{"award-number":["18H03187"]}]},{"name":"Grant-in-Aid for Challenging Exploratory Research","award":["19K22791"],"award-info":[{"award-number":["19K22791"]}]},{"DOI":"10.13039\/100008695","name":"Japan Foundation for Applied Enzymology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008695","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hokkaido Heart Association Grant for Research"},{"name":"MSD Life Science Foundation"},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiovascular Research Fund, Tokyo, Japan"},{"name":"Fukuda Memorial Foundation for Medical Research"},{"name":"Kimura Memorial Heart Foundation Research Grant for 2017"},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013642","name":"Japan Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013642","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sasakawa Scientific Research Grant from The Japan Science Society"},{"name":"Center of Innovation Program from the Japan Science and Technology Agency"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transforming growth factor beta (TGF-\u03b2)-Smad2\/3 is the major signaling pathway of fibrosis, which is characterized by the excessive production and accumulation of extracellular matrix (ECM) components, including collagen. Although the ECM is an essential component of skeletal muscle, fibrosis may be harmful to muscle function. On the other hand, our previous studies have shown that levels of angiotensin II, which acts upstream of TGF-\u03b2-Smad2\/3 signaling, is increased in mice with myocardial infarction (MI). In this study, we found higher skeletal muscle fibrosis in MI mice compared with control mice, and we investigated the mechanisms involved therein. Moreover, we administered an inhibitor based on the above mechanism and investigated its preventive effects on skeletal muscle fibrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Male C57BL\/6\u2009J mice with MI were created, and sham-operated mice were used as controls. The time course of skeletal muscle fibrosis post-MI was analyzed by picrosirius-red staining (days 1, 3, 7, and 14). Mice were then divided into 3 groups: sham + vehicle (Sham + Veh), MI + Veh, and MI + lisinopril (an angiotensin-converting enzyme [ACE] inhibitor, 20\u2009mg\/kg body weight\/day in drinking water; MI + Lis). Lis or Veh was administered from immediately after the surgery to 14\u2009days postsurgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Skeletal muscle fibrosis was significantly increased in MI mice compared with sham mice from 3 to 14\u2009days postsurgery. Although mortality was lower in the MI + Lis mice than the MI + Veh mice, there was no difference in cardiac function between the 2 groups at 14\u2009days. Skeletal muscle fibrosis and hydroxyproline (a key marker of collagen content) were significantly increased in MI + Veh mice compared with the Sham + Veh mice. Consistent with these results, protein expression of TGF-\u03b2 and phosphorylated Smad2\/3 in the skeletal muscle during the early time points after surgery (days 1\u20137 postsurgery) and blood angiotensin II at 14\u2009days postsurgery was increased in MI mice compared with sham mice. These impairments were improved in MI + Lis mice, without any effects on spontaneous physical activity, muscle strength, muscle weight, and blood pressure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ACE inhibitor administration prevents increased skeletal muscle fibrosis during the early phase after MI. Our findings indicate a new therapeutic target for ameliorating skeletal muscle abnormalities in heart diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13395-020-00230-9","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T04:04:21Z","timestamp":1587787461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice"],"prefix":"10.1186","volume":"10","author":[{"given":"Naoya","family":"Kakutani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Nambu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Furihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arata","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"230_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"372","author":"DC Rockey","year":"2015","unstructured":"Rockey DC, Bell PD, Hill JA. Fibrosis--a common pathway to organ injury and failure. N Engl J Med. 2015;372:1138\u201349.","journal-title":"N Engl J Med"},{"key":"230_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","volume":"117","author":"TA Wynn","year":"2007","unstructured":"Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524\u20139.","journal-title":"J Clin Invest"},{"key":"230_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.kint.2016.07.029","volume":"91","author":"J Dong","year":"2017","unstructured":"Dong J, Dong Y, Chen Z, Mitch WE, Zhang L. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro\/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 2017;91:119\u201328.","journal-title":"Kidney Int"},{"key":"230_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13395-019-0197-y","volume":"9","author":"Q Jin","year":"2019","unstructured":"Jin Q, et al. A GDF11\/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice. Skelet Muscle. 2019;9:16.","journal-title":"Skelet Muscle"},{"key":"230_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13395-018-0179-5","volume":"8","author":"AN Billin","year":"2018","unstructured":"Billin AN, et al. HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury. Skelet Muscle. 2018;8:35.","journal-title":"Skelet Muscle"},{"key":"230_CR6","doi-asserted-by":"crossref","unstructured":"Rebolledo DL, et al. Denervation-induced skeletal muscle fibrosis is mediated by CTGF\/CCN2 independently of TGF-beta. Matrix Biol. 2019.","DOI":"10.1016\/j.matbio.2019.01.002"},{"key":"230_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2012.00071","volume":"3","author":"S Ueha","year":"2012","unstructured":"Ueha S, Shand FH, Matsushima K. Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis. Front Immunol. 2012;3:71.","journal-title":"Front Immunol"},{"key":"230_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.15-108","volume":"56","author":"S Kinugawa","year":"2015","unstructured":"Kinugawa S, Takada S, Matsushima S, Okita K, Tsutsui H. Skeletal muscle abnormalities in heart failure. Int Heart J. 2015;56:475\u201384.","journal-title":"Int Heart J"},{"key":"230_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1253\/circrep.CR-19-0004","volume":"1","author":"N Kakutani","year":"2019","unstructured":"Kakutani N, et al. Progressive mobilization program for patients with acute heart failure reduces hospital stay and improves clinical outcome. Circ Rep. 2019;1:123\u201330.","journal-title":"Circ Rep"},{"key":"230_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1253\/circj.CJ-18-0103","volume":"82","author":"N Kakutani","year":"2018","unstructured":"Kakutani N, et al. Impact of high respiratory exchange ratio during submaximal exercise on adverse clinical outcome in heart failure. Circ J. 2018;82:2753\u201360.","journal-title":"Circ J"},{"key":"230_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/cvr\/cvw182","volume":"111","author":"S Takada","year":"2016","unstructured":"Takada S, et al. Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling. Cardiovasc Res. 2016;111:338\u201347.","journal-title":"Cardiovasc Res"},{"key":"230_CR12","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/CIRCULATIONAHA.118.035212","volume":"138","author":"J Matsumoto","year":"2018","unstructured":"Matsumoto J, et al. Brain-derived neurotrophic factor improves limited exercise capacity in mice with heart failure. Circulation. 2018;138:2064\u20136.","journal-title":"Circulation."},{"key":"230_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/jcsm.12322","volume":"9","author":"M Tsuda","year":"2018","unstructured":"Tsuda M, et al. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure. J Cachexia Sarcopenia Muscle. 2018;9:844\u201359.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"230_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ijcard.2014.07.113","volume":"176","author":"K Hirabayashi","year":"2014","unstructured":"Hirabayashi K, et al. Intramyocellular lipid is increased in the skeletal muscle of patients with dilated cardiomyopathy with lowered exercise capacity. Int J Cardiol. 2014;176:1110\u20132.","journal-title":"Int J Cardiol"},{"key":"230_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijcard.2015.08.022","volume":"201","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, et al. Low-intensity exercise under ischemic conditions enhances metabolic stress in patients with heart failure. Int J Cardiol. 2015;201:142\u20134.","journal-title":"Int J Cardiol"},{"key":"230_CR16","unstructured":"Nakano I, et al. Enhanced echo intensity of skeletal muscle is associated with exercise intolerance in patients with heart failure. J Card Fail. 2019."},{"key":"230_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2044-5040-4-6","volume":"4","author":"D Cabrera","year":"2014","unstructured":"Cabrera D, et al. Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis. Skelet Muscle. 2014;4:6.","journal-title":"Skelet Muscle"},{"key":"230_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/37284","volume":"390","author":"CH Heldin","year":"1997","unstructured":"Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465\u201371.","journal-title":"Nature."},{"key":"230_CR19","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.febslet.2012.03.063","volume":"586","author":"Z Zi","year":"2012","unstructured":"Zi Z, Chapnick DA, Liu X. Dynamics of TGF-beta\/Smad signaling. FEBS Lett. 2012;586:1921\u20138.","journal-title":"FEBS Lett"},{"key":"230_CR20","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Phys Cell Physiol. 2007;292:C82\u201397.","journal-title":"Am J Phys Cell Physiol"},{"key":"230_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/labinvest.2016.52","volume":"96","author":"SA Khan","year":"2016","unstructured":"Khan SA, et al. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-beta. Lab Investig. 2016;96:773\u201383.","journal-title":"Lab Investig"},{"key":"230_CR22","doi-asserted-by":"publisher","first-page":"E503","DOI":"10.1152\/ajpendo.00449.2013","volume":"307","author":"A Fukushima","year":"2014","unstructured":"Fukushima A, et al. (Pro)renin receptor in skeletal muscle is involved in the development of insulin resistance associated with postinfarct heart failure in mice. Am J Physiol Endocrinol Metab. 2014;307:E503\u201314.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"230_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2016.03.022","volume":"779","author":"A Fukushima","year":"2016","unstructured":"Fukushima A, et al. Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice. Eur J Pharmacol. 2016;779:147\u201356.","journal-title":"Eur J Pharmacol"},{"key":"230_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","volume":"63","author":"VJ Dzau","year":"1981","unstructured":"Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981;63:645\u201351.","journal-title":"Circulation."},{"key":"230_CR25","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","volume":"345","author":"JN Cohn","year":"2001","unstructured":"Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667\u201375.","journal-title":"N Engl J Med"},{"key":"230_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.RES.87.5.392","volume":"87","author":"S Kinugawa","year":"2000","unstructured":"Kinugawa S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res. 2000;87:392\u20138.","journal-title":"Circ Res"},{"key":"230_CR27","doi-asserted-by":"publisher","first-page":"H409","DOI":"10.1152\/ajpheart.01332.2008","volume":"297","author":"S Matsushima","year":"2009","unstructured":"Matsushima S, et al. Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2009;297:H409\u201316.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"230_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1291\/hypres.23.625","volume":"23","author":"T Kai","year":"2000","unstructured":"Kai T, Ishikawa K. Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wall stress in transgenic Tsukuba hypertensive mice. Hypertension research: official journal of the Japanese Society of Hypertension. 2000;23:625\u201331.","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"key":"230_CR29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1113\/EP085251","volume":"100","author":"S Takada","year":"2015","unstructured":"Takada S, et al. Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice with high-fat diet-induced diabetes. Exp Physiol. 2015;100:1319\u201330.","journal-title":"Exp Physiol"},{"key":"230_CR30","doi-asserted-by":"publisher","first-page":"35669","DOI":"10.1074\/jbc.M112.357871","volume":"287","author":"M Nakaya","year":"2012","unstructured":"Nakaya M, et al. Induction of cardiac fibrosis by beta-blocker in G protein-independent and G protein-coupled receptor kinase 5\/beta-arrestin2-dependent signaling pathways. J Biol Chem. 2012;287:35669\u201377.","journal-title":"J Biol Chem"},{"key":"230_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1113\/expphysiol.2014.084095","volume":"100","author":"T Kadoguchi","year":"2015","unstructured":"Kadoguchi T, et al. Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle. Exp Physiol. 2015;100:312\u201322.","journal-title":"Exp Physiol"},{"key":"230_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12964-019-0445-0","volume":"17","author":"S Maekawa","year":"2019","unstructured":"Maekawa S, et al. Linoleic acid improves assembly of the CII subunit and CIII2\/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure. Cell Commun Signal. 2019;17:128.","journal-title":"Cell Commun Signal"},{"key":"230_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s003950050183","volume":"95","author":"LA Zornoff","year":"2000","unstructured":"Zornoff LA, Matsubara BB, Matsubara LS, Paiva SA, Spadaro J. Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats. Basic Res Cardiol. 2000;95:208\u201314.","journal-title":"Basic Res Cardiol"},{"key":"230_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00441-013-1642-6","volume":"353","author":"MG Morales","year":"2013","unstructured":"Morales MG, et al. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF\/CCN-2). Cell Tissue Res. 2013;353:173\u201387.","journal-title":"Cell Tissue Res"},{"key":"230_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2044-5040-1-21","volume":"1","author":"CJ Mann","year":"2011","unstructured":"Mann CJ, et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle. 2011;1:21.","journal-title":"Skelet Muscle"},{"key":"230_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/03008207.2016.1257004","volume":"58","author":"A Yoshimura","year":"2017","unstructured":"Yoshimura A, et al. Cyclic muscle twitch contraction inhibits immobilization-induced muscle contracture and fibrosis in rats. Connect Tissue Res. 2017;58:487\u201395.","journal-title":"Connect Tissue Res"},{"key":"230_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0735-1097(87)80204-8","volume":"10","author":"A Dunnigan","year":"1987","unstructured":"Dunnigan A, et al. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol. 1987;10:608\u201318.","journal-title":"J Am Coll Cardiol"},{"key":"230_CR38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ijcard.2012.03.063","volume":"167","author":"RL Damatto","year":"2013","unstructured":"Damatto RL, et al. Heart failure-induced skeletal myopathy in spontaneously hypertensive rats. Int J Cardiol. 2013;167:698\u2013703.","journal-title":"Int J Cardiol"},{"key":"230_CR39","doi-asserted-by":"publisher","first-page":"H1637","DOI":"10.1152\/ajpheart.01185.2009","volume":"300","author":"Y Ohta","year":"2011","unstructured":"Ohta Y, et al. Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure. Am J Physiol Heart Circ Physiol. 2011;300:H1637\u201344.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"230_CR40","doi-asserted-by":"publisher","first-page":"H1202","DOI":"10.1152\/ajpheart.00534.2011","volume":"302","author":"N Inoue","year":"2012","unstructured":"Inoue N, et al. Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle. Am J Physiol Heart Circ Physiol. 2012;302:H1202\u201310.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"230_CR41","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1369\/jhc.4A6560.2005","volume":"53","author":"RG Dean","year":"2005","unstructured":"Dean RG, et al. Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem. 2005;53:1245\u201356.","journal-title":"J Histochem Cytochem"},{"key":"230_CR42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nature20160","volume":"540","author":"AA Mueller","year":"2016","unstructured":"Mueller AA, van Velthoven CT, Fukumoto KD, Cheung TH, Rando TA. Intronic polyadenylation of PDGFRalpha in resident stem cells attenuates muscle fibrosis. Nature. 2016;540:276\u20139.","journal-title":"Nature."},{"key":"230_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41419-018-0573-2","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang Z, et al. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. Cell Death Dis. 2018;9:613.","journal-title":"Cell Death Dis"},{"key":"230_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.kint.2018.10.017","volume":"95","author":"J Nakamura","year":"2019","unstructured":"Nakamura J, et al. Myofibroblasts acquire retinoic acid-producing ability during fibroblast-to-myofibroblast transition following kidney injury. Kidney Int. 2019;95:526\u201339.","journal-title":"Kidney Int"},{"key":"230_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119\u201377.","journal-title":"Eur Heart J"},{"key":"230_CR46","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","volume":"61","author":"PT O'Gara","year":"2013","unstructured":"O'Gara PT, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78\u2013e140.","journal-title":"J Am Coll Cardiol"},{"key":"230_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1152\/physrev.00031.2003","volume":"84","author":"M Kjaer","year":"2004","unstructured":"Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev. 2004;84:649\u201398.","journal-title":"Physiol Rev"},{"key":"230_CR48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mus.22094","volume":"44","author":"AR Gillies","year":"2011","unstructured":"Gillies AR, Lieber RL. Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve. 2011;44:318\u201331.","journal-title":"Muscle Nerve"},{"key":"230_CR49","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;301:H2181\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"230_CR50","first-page":"F1658","volume":"315","author":"MK Abramowitz","year":"2018","unstructured":"Abramowitz MK, et al. Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease. Am J Phys Renal Phys. 2018;315:F1658\u2013F69.","journal-title":"Am J Phys Renal Phys"},{"key":"230_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00276-013-1185-2","volume":"36","author":"A Stecco","year":"2014","unstructured":"Stecco A, Meneghini A, Stern R, Stecco C, Imamura M. Ultrasonography in myofascial neck pain: randomized clinical trial for diagnosis and follow-up. Surg Radiol Anat. 2014;36:243\u201353.","journal-title":"Surg Radiol Anat"},{"key":"230_CR52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1017\/S0012162201000597","volume":"43","author":"CM Booth","year":"2001","unstructured":"Booth CM, Cortina-Borja MJ, Theologis TN. Collagen accumulation in muscles of children with cerebral palsy and correlation with severity of spasticity. Dev Med Child Neurol. 2001;43:314\u201320.","journal-title":"Dev Med Child Neurol"},{"key":"230_CR53","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","volume":"359","author":"G Onder","year":"2002","unstructured":"Onder G, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359:926\u201330.","journal-title":"Lancet."}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00230-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-020-00230-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00230-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T23:53:21Z","timestamp":1619308401000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-020-00230-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,25]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1186\/s13395-020-00230-9","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,25]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures and animal care were approved by our institutional animal research committee and conformed to the animal care guidelines for the Care and Use of Laboratory Animals at Hokkaido University Faculty of Medicine and Graduate School of Medicine. The procedures and care of animals were also in accordance with the relevant national and international guidelines and the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}